ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Snook, J, Chapman, R, Fleming, K, Jewell, D
Μορφή:	Journal article
Έκδοση:	1988

Παρόμοια τεκμήρια

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
ανά: Snook, J, κ.ά.
Έκδοση: (1989)

The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
ανά: Mehal, W, κ.ά.
Έκδοση: (1994)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
ανά: Snook, J, κ.ά.
Έκδοση: (1987)

Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
ανά: Lo, S, κ.ά.
Έκδοση: (1992)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
ανά: Lo, S, κ.ά.
Έκδοση: (1991)

Primary sclerosing cholangitis--an immunologically mediated disease?
ανά: Chapman, R, κ.ά.
Έκδοση: (1985)

Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
ανά: Saich, R, κ.ά.
Έκδοση: (2008)

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.
ανά: Snook, J, κ.ά.
Έκδοση: (1989)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
ανά: Snook, J, κ.ά.
Έκδοση: (1989)

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
ανά: You Sun Kim, κ.ά.
Έκδοση: (2023-10-01)

The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
ανά: Chapman, R
Έκδοση: (1995)

International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
ανά: Williamson, K, κ.ά.
Έκδοση: (2018)

SERUM ANTI-COLON ANTIBODIES, ULCERATIVE-COLITIS, AND SCLEROSING CHOLANGITIS
ανά: Chapman, R, κ.ά.
Έκδοση: (1983)

Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases
ανά: Lynch, K, κ.ά.
Έκδοση: (2019)

Chromoendoscopy in colorectal surveillance for primary sclerosing cholangitis and inflammatory bowel disease
ανά: Rodrigo V Motta, κ.ά.
Έκδοση: (2025-01-01)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
ανά: Satsangi, J, κ.ά.
Έκδοση: (2000)

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
ανά: Boberg, K, κ.ά.
Έκδοση: (2001)

Primary sclerosing cholangitis
ανά: Chapman, R
Έκδοση: (2007)

Primary sclerosing cholangitis.
ανά: Chapman, R
Έκδοση: (1985)

Primary sclerosing cholangitis.
ανά: Cullen, S, κ.ά.
Έκδοση: (2003)

Primary sclerosing cholangitis.
ανά: Mitchell, SA, κ.ά.
Έκδοση: (2000)

Primary sclerosing cholangitis.
ανά: Williamson, K, κ.ά.
Έκδοση: (2014)

Primary sclerosing cholangitis.
ανά: Worthington, J, κ.ά.
Έκδοση: (2006)

Primary sclerosing cholangitis
ανά: Chapman Roger, κ.ά.
Έκδοση: (2006-10-01)

Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
ανά: Ananthakrishnan, Ashwin N., κ.ά.
Έκδοση: (2016)

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases
ανά: Joanna Saganek, κ.ά.
Έκδοση: (2023-09-01)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
ανά: Kwang Woo Kim, κ.ά.
Έκδοση: (2023-10-01)

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
ανά: Arshdeep Singh, κ.ά.
Έκδοση: (2023-10-01)

Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis
ανά: Ingvar Bjarnason, κ.ά.
Έκδοση: (2015-10-01)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
ανά: Cameron, B, κ.ά.
Έκδοση: (1998)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
ανά: Bansi, D, κ.ά.
Έκδοση: (1995)

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment.
ανά: Lo, S, κ.ά.
Έκδοση: (1994)

SERUM PROCOLLAGEN III N-TERMINAL PEPTIDE IN PRIMARY SCLEROSING CHOLANGITIS
ανά: Snook, J, κ.ά.
Έκδοση: (1988)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
ανά: Martins, E, κ.ά.
Έκδοση: (1995)

FEMALES WITH PRIMARY SCLEROSING CHOLANGITIS WITHOUT INFLAMMATORY BOWEL DISEASES HAVE A BETTER PROGNOSIS: IS IT DIFFERENT DISEASE?
ανά: Al Mamari, S, κ.ά.
Έκδοση: (2013)

The management of primary sclerosing cholangitis.
ανά: Chapman, R
Έκδοση: (2003)

The immunology of primary sclerosing cholangitis.
ανά: Chapman, R
Έκδοση: (1990)

Primary sclerosing cholangitis - Foreword
ανά: Chapman, R
Έκδοση: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
ανά: Chapman, R
Έκδοση: (1993)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
ανά: Bansi, D, κ.ά.
Έκδοση: (1995)